These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 32132065)

  • 21. Expression of insulin-like growth-factor-1 receptor (IGF-1R) in peripheral nerve sheath tumors in neurofibromatosis type 1.
    Friedrich RE; Keiner D; Hagel C
    Anticancer Res; 2007; 27(4A):2085-90. PubMed ID: 17649826
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Systemic Options for Malignant Peripheral Nerve Sheath Tumors.
    Hassan A; Pestana RC; Parkes A
    Curr Treat Options Oncol; 2021 Feb; 22(4):33. PubMed ID: 33641042
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Calebin-A induced death of malignant peripheral nerve sheath tumor cells by activation of histone acetyltransferase.
    Lee MJ; Tsai YJ; Lin MY; You HL; Kalyanam N; Ho CT; Pan MH
    Phytomedicine; 2019 Apr; 57():377-384. PubMed ID: 30831486
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Malignant peripheral nerve sheath tumor of the maxilla: Case report and review of the literature with emphasis on its poor prognosis.
    Oh KY; Hong SD
    Oral Oncol; 2022 Dec; 135():106211. PubMed ID: 36257181
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ifosfamide, carboplatin and etoposide (ICE) as second-line regimen alone and in combination with regional hyperthermia is active in chemo-pre-treated advanced soft tissue sarcoma of adults.
    Fiegl M; Schlemmer M; Wendtner CM; Abdel-Rahman S; Fahn W; Issels RD
    Int J Hyperthermia; 2004 Sep; 20(6):661-70. PubMed ID: 15370821
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A case of intra-dural malignant peripheral nerve sheath tumor in thoracic spine associated with neurofibromatosis type 1.
    Albayrak BS; Gorgulu A; Kose T
    J Neurooncol; 2006 Jun; 78(2):187-90. PubMed ID: 16598431
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Malignant Peripheral Nerve Sheath Tumor of the Cervix.
    Zhang T; Wang Z; Wang R; Wu X; Zhao M; Su F
    J Coll Physicians Surg Pak; 2022 Apr; 32(4):S24-S27. PubMed ID: 35633002
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A threefold dose intensity treatment with ifosfamide, carboplatin, and etoposide for patients with small cell lung cancer: a randomized trial.
    Leyvraz S; Pampallona S; Martinelli G; Ploner F; Perey L; Aversa S; Peters S; Brunsvig P; Montes A; Lange A; Yilmaz U; Rosti G;
    J Natl Cancer Inst; 2008 Apr; 100(8):533-41. PubMed ID: 18398095
    [TBL] [Abstract][Full Text] [Related]  

  • 29. FNAC diagnosis of MPNST--a case report.
    Yadavrao KA; Vijaykumar WJ; Kanthirav KG
    Indian J Pathol Microbiol; 2005 Jul; 48(3):383-5. PubMed ID: 16761762
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ifosfamide, carboplatin and etoposide (ICE) in metastatic and refractory breast cancer.
    Chang AY; Hui L; Asbury R; Boros L; Garrow G; Rubins J
    Cancer Chemother Pharmacol; 1999; 44 Suppl():S26-8. PubMed ID: 10602907
    [TBL] [Abstract][Full Text] [Related]  

  • 31. ICE Regimen for Relapsed/Refractory Bone and Soft Tissue Sarcomas in Children.
    Aydin B; Akyuz C; Varan A; Yalcin B; Kurucu N; Kutluk T
    Rev Recent Clin Trials; 2018; 13(2):126-131. PubMed ID: 29366426
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tumor expression of survivin, p53, cyclin D1, osteopontin and fibronectin in predicting the response to neo-adjuvant chemotherapy in children with advanced malignant peripheral nerve sheath tumor.
    Karpinsky G; Krawczyk MA; Izycka-Swieszewska E; Fatyga A; Budka A; Balwierz W; Sobol G; Zalewska-Szewczyk B; Rychlowska-Pruszynska M; Klepacka T; Dembowska-Baginska B; Kazanowska B; Gabrych A; Bien E
    J Cancer Res Clin Oncol; 2018 Mar; 144(3):519-529. PubMed ID: 29332262
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High-dose ifosfamide, carboplatin and etoposide with autologous peripheral blood progenitor cell transplantation for small-cell lung cancer.
    Bessho A; Ueoka H; Kiura K; Tabata M; Sunami K; Katayama Y; Yamane H; Hiraki A; Harada M
    Anticancer Res; 1999; 19(1B):693-8. PubMed ID: 10216478
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Malignant peripheral nerve sheath tumor of the bladder A case report.
    Petracco G; Patriarca C; Spasciani R; Parafioriti A
    Pathologica; 2019 Dec; 111(4):365-368. PubMed ID: 31965114
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long survival after resection for lung metastasis of malignant peripheral nerve sheath tumor in neurofibromatosis 1.
    Shimizu K; Okita R; Uchida Y; Hihara J
    Ann Thorac Cardiovasc Surg; 2008 Oct; 14(5):322-4. PubMed ID: 18989250
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Possible contribution of aprepitant to ifosfamide-induced neurotoxicity.
    Jarkowski A
    Am J Health Syst Pharm; 2008 Dec; 65(23):2229-31. PubMed ID: 19020190
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Histopathology and clinical outcome of NF1-associated vs. sporadic malignant peripheral nerve sheath tumors.
    Hagel C; Zils U; Peiper M; Kluwe L; Gotthard S; Friedrich RE; Zurakowski D; von Deimling A; Mautner VF
    J Neurooncol; 2007 Apr; 82(2):187-92. PubMed ID: 17111191
    [TBL] [Abstract][Full Text] [Related]  

  • 38. NF1 deficiency causes Bcl-xL upregulation in Schwann cells derived from neurofibromatosis type 1-associated malignant peripheral nerve sheath tumors.
    Park HJ; Lee SJ; Sohn YB; Jin HS; Han JH; Kim YB; Yim H; Jeong SY
    Int J Oncol; 2013 Feb; 42(2):657-66. PubMed ID: 23292448
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Malignant Peripheral Nerve Sheath Tumor.
    James AW; Shurell E; Singh A; Dry SM; Eilber FC
    Surg Oncol Clin N Am; 2016 Oct; 25(4):789-802. PubMed ID: 27591499
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Early tandem high-dose ifosfamide, carboplatin, etoposide therapy with stem cell rescue for small-cell lung cancer: brief report on the results of a phase-I/II trial.
    Oelmann E; Thomas M; Serve H; Kienast J; Zühlsdorf M; Mohr M; Klinke F; Dölken G; Macha H; Schmidt EW; Berdel WE
    Oncology; 2002; 63(3):248-53. PubMed ID: 12381904
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.